- This event has passed.
Exploring OFEV® (nintedanib) capsules: A Treatment Journey
October 18, 2021 from 12:20 pm - 1:05 pm CDT
Supported By: Boehringer Ingelheim Pharmaceuticals, Inc.
Join Drs. Toby Maher and Joseph Mammarappallil as they review the pivotal safety and efficacy data for OFEV and explore a case study that highlights the identification of patients for appropriate treatment. This presentation is made of behalf of Boehringer Ingelheim Pharmaceuticals, Inc.
Toby Maher, MD
Keck Medicine of USC
Professor of Clinical Medicine
Los Angeles, California
Joseph G. Mammarappallil, MD, PhD
Duke University School of Medicine
Assistant Professor of Radiology
Durham, North Carolina